InvestorsHub Logo
Followers 139
Posts 23227
Boards Moderated 0
Alias Born 04/08/2004

Re: kspar1 post# 457577

Wednesday, 04/24/2024 10:51:55 PM

Wednesday, April 24, 2024 10:51:55 PM

Post# of 463357
Anavex 3-71 (formerly known as AF710b)

"..."We are thrilled to partner with Anavex in this very important trial," said Matt Bevin, CEO at Cognision. "Our advanced EEG/ERP technology will provide early insights on the neural response to ANAVEX®3-71 in individuals with schizophrenia, possibly paving the way for more effective and targeted therapeutic interventions for this very vulnerable population."..."



"...Anavex chose to partner with Cognision and utilize the COGNISION® System because of the system's ability to precisely measure drug-induced changes in brain function in the small cohorts commonly used in early-phase trials. These measures are obtained during electroencephalographic (EEG) and event-related potential (ERP) testing sessions after subjects are dosed with either ANAVEX®3-71 or a placebo. With this EEG/ERP technology, potentially therapeutic effects of novel compounds can be detected at an early stage in a clinical trial program...."



https://www.openpr.com/news/3473833/cognision-partners-with-anavex-for-phase-2-study-of-anavex-3-71

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News